AI Engines For more Details: Perplexity Kagi Labs You
Anti-inflammatory Properties: AITC, the main bioactive compound in wasabi, exhibits anti-inflammatory properties. It may help reduce inflammation in the body, which is associated with various chronic conditions such as arthritis, cardiovascular disease, and inflammatory bowel disease.
Antimicrobial Activity: AITC has been shown to possess antimicrobial properties, which may help inhibit the growth of bacteria, viruses, and fungi. This antimicrobial activity may contribute to the preservation of food and may also have implications for supporting immune health.
Cancer Prevention: Some research suggests that AITC and other compounds found in cruciferous vegetables, including wasabi, may have chemopreventive effects against certain types of cancer. These compounds may help inhibit the growth of cancer cells, induce apoptosis (cell death) in cancer cells, and prevent the formation of tumors.
Digestive Health: Wasabi consumption may support digestive health due to its potential antimicrobial properties and ability to stimulate digestive enzyme production. It may aid in the digestion of food and help prevent gastrointestinal infections caused by pathogenic bacteria.
Nasal Decongestant: The pungent aroma of wasabi can act as a natural nasal decongestant. Inhaling the vapor from freshly grated wasabi may help clear nasal passages and provide relief from congestion associated with allergies, colds, or sinusitis.
Cardiovascular Health: Some studies suggest that AITC may have cardiovascular benefits, including potential vasodilatory effects that could help lower blood pressure and improve circulation. However, more research is needed to fully understand the impact of AITC on cardiovascular health.
Antiplatelet Activity: AITC has been investigated for its potential antiplatelet activity, which means it may help prevent excessive blood clotting. This could have implications for reducing the risk of blood clots, heart attacks, and strokes, although more research is necessary to confirm these effects.
Pain Relief: Topical application of AITC-containing creams or ointments may provide temporary pain relief for conditions such as arthritis, muscle soreness, or neuropathic pain. The compound is believed to work by desensitizing pain receptors and reducing pain signals sent to the brain.
Rank | Probiotic | Impact |
---|---|---|
species | Bifidobacterium adolescentis | Increases |
species | Bifidobacterium bifidum | Increases |
species | Bifidobacterium breve | Increases |
species | Bifidobacterium catenulatum | Increases |
species | Bifidobacterium longum | Increases |
species | Bifidobacterium pseudocatenulatum | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 1.2 | 1.2 | |
ADHD | 1.5 | -1.5 | |
Allergic Rhinitis (Hay Fever) | 1.4 | 1.4 | |
Allergies | 0.5 | 0.9 | -0.8 |
Allergy to milk products | 0.9 | 0.9 | |
Alopecia (Hair Loss) | 0.5 | -0.5 | |
Alzheimer's disease | 1.2 | 1.8 | -0.5 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | -0.6 | |
Ankylosing spondylitis | 0.8 | -0.8 | |
Asthma | 0.5 | 0.6 | -0.2 |
Atherosclerosis | 0.8 | -0.8 | |
Atrial fibrillation | 0.6 | 0.8 | -0.33 |
Autism | 2.2 | 2 | 0.1 |
Barrett esophagus cancer | 0.3 | 0.6 | -1 |
Brain Trauma | 1.1 | -1.1 | |
Breast Cancer | 0.3 | 0.3 | |
Carcinoma | 0.8 | 0.8 | 0 |
Celiac Disease | 1.4 | 0.8 | 0.75 |
Cerebral Palsy | 0.6 | -0.6 | |
Chronic Fatigue Syndrome | 0.6 | 0.6 | 0 |
Chronic Kidney Disease | 0.2 | 0.2 | |
Chronic Urticaria (Hives) | 0.6 | -0.6 | |
Colorectal Cancer | 1.1 | 1.5 | -0.36 |
Constipation | 0.3 | 0.3 | |
Coronary artery disease | 0.8 | -0.8 | |
COVID-19 | 2 | 1.3 | 0.54 |
Crohn's Disease | 1.7 | 1.4 | 0.21 |
cystic fibrosis | 0.6 | 0.6 | |
Depression | 2.1 | 2.2 | -0.05 |
Dermatomyositis | 0.6 | 0.6 | |
Eczema | 0.9 | 0.6 | 0.5 |
Endometriosis | 1.2 | -1.2 | |
Epilepsy | 0.6 | 1.4 | -1.33 |
erectile dysfunction | 0.2 | -0.2 | |
Fibromyalgia | 0.6 | 0.6 | |
Functional constipation / chronic idiopathic constipation | 0.9 | 1.1 | -0.22 |
gallstone disease (gsd) | 0.6 | 0.6 | |
Generalized anxiety disorder | 0.8 | 0.8 | |
Gout | 0.3 | -0.3 | |
Graves' disease | 0.2 | 2 | -9 |
Hashimoto's thyroiditis | 0.6 | 0.6 | 0 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.3 | 0.6 | -1 |
hypercholesterolemia (High Cholesterol) | 0.3 | 1.2 | -3 |
hyperglycemia | 1.2 | 0.6 | 1 |
Hyperlipidemia (High Blood Fats) | 0.5 | 0.8 | -0.6 |
hypersomnia | 0.3 | 0.3 | |
hypertension (High Blood Pressure | 1.2 | 2.3 | -0.92 |
Hypothyroidism | 0.6 | 0.6 | |
IgA nephropathy (IgAN) | 0.6 | 0.3 | 1 |
Inflammatory Bowel Disease | 0.8 | 1.4 | -0.75 |
Intelligence | 1.2 | 1.2 | |
Intracranial aneurysms | 0.2 | 0.2 | |
Irritable Bowel Syndrome | 1.2 | 1.2 | 0 |
Liver Cirrhosis | 0.6 | 0.6 | 0 |
Long COVID | 2.9 | 2.8 | 0.04 |
ME/CFS with IBS | 0.6 | 0.6 | |
ME/CFS without IBS | 0.6 | 0.6 | |
Menopause | 0.2 | 0.4 | -1 |
Metabolic Syndrome | 3.1 | 3.4 | -0.1 |
Mood Disorders | 2.4 | 2.4 | 0 |
multiple chemical sensitivity [MCS] | 0.3 | 0.3 | |
Multiple Sclerosis | 0.8 | 0.8 | 0 |
Multiple system atrophy (MSA) | 0.8 | 0.8 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.3 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.2 | 0.5 | 1.4 |
NonCeliac Gluten Sensitivity | 0.6 | 0.6 | |
Obesity | 1 | 2.3 | -1.3 |
obsessive-compulsive disorder | 0.8 | 0.6 | 0.33 |
Osteoarthritis | 0.2 | 0.2 | |
Osteoporosis | 0.3 | 0.3 | |
pancreatic cancer | 0.2 | 0.2 | |
Parkinson's Disease | 0.2 | 1.6 | -7 |
Polycystic ovary syndrome | 0.6 | 0.9 | -0.5 |
Postural orthostatic tachycardia syndrome | 0.6 | 0.6 | |
Premenstrual dysphoric disorder | 0.8 | -0.8 | |
primary biliary cholangitis | 0.2 | 0.3 | -0.5 |
Psoriasis | 0.6 | -0.6 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.1 | 2 | -0.82 |
Rosacea | 0.6 | -0.6 | |
Schizophrenia | 1.5 | 1.2 | 0.25 |
Sjögren syndrome | 0.8 | 0.8 | |
Sleep Apnea | 0.6 | -0.6 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.2 | 0.2 | |
Stress / posttraumatic stress disorder | 1 | 1.5 | -0.5 |
Systemic Lupus Erythematosus | 0.6 | 0.6 | |
Tic Disorder | 0.8 | 0.8 | |
Type 1 Diabetes | 0.4 | 0.4 | |
Type 2 Diabetes | 1.6 | 2.5 | -0.56 |
Ulcerative colitis | 0.8 | 1.2 | -0.5 |
Unhealthy Ageing | 1.2 | 1.2 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.